PB Fintech’s stock surged over 4% after CEO Yashish Dahiya announced plans for a $100 million investment to acquire a 30% stake in a new healthcare company, pending board approval. This strategic move aims to address the significant gap between healthcare costs and affordability for the average Indian.
Brokerage firm Bernstein has maintained an ‘outperform’ rating for PB Fintech, setting a…
Ahammune Biosciences, an innovative biotech firm focused on dermatological therapies, has successfully raised $5 million in a Series A funding round led by the early-stage venture capital firm pi Ventures. This funding round also welcomed participation from Capital2B, Colossa Ventures, Bipin Agarwal, Unicornus Maximus LLP, along with existing investors such as Ideaspring Capital, Kotak Alternate…
